Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Xoma Corp (NQ: XOMA )

20.58 -0.26 (-1.25%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 8, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 34,745
Open 20.61
Bid (Size) 19.97 (1)
Ask (Size) 29.00 (1)
Prev. Close 20.84
Today's Range 19.39 - 20.77
52wk Range 16.96 - 32.75
Shares Outstanding 11,450,823
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
XOMA Earnings Perspective: Return On Capital Employed
Benzinga Pro data, XOMA (NASDAQ:XOMA) reported Q1 sales of $3.11 million. Earnings fell to a loss of $2.28 million, resulting in a 107.64% decrease from last quarter. In Q4, XOMA earned $29.84 million,... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's trading, 435 companies set new 52-week lows. 
Via Benzinga

Performance

YTD
-0.91%
-0.91%
1 Month
-25.05%
-25.05%
3 Month
+17.06%
+17.06%
6 Month
+2.54%
+2.54%
1 Year
-37.16%
-37.16%

More News

Read More
Recap: XOMA Q4 Earnings
Via Benzinga
XOMA's Return On Capital Employed Insights
Via Benzinga
50 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
XOMA's Return On Capital Employed Overview
Via Benzinga
XOMA's Return On Capital Employed Overview
Via Benzinga
Why Did Wedbush Downgrade Xoma?
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2021
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Recap: XOMA Q2 Earnings
Via Benzinga
Why XOMA Stock Is Trading Higher Wednesday?
Via Benzinga
Exposures Product Safety
XOMA Buys Royalty, Milestone Interest In Checkmate's Vidutolimod From Kuros Biosciences
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2021
Via Benzinga
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
58 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.